Found: 13
Select item for more details and to access through your institution.
Challenges and opportunities in the immunotherapy era: balancing expectations with hope in small-cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241249627
- By:
- Publication type:
- Article
Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6877
- By:
- Publication type:
- Article
Antibody-drug conjugates in lung cancer: dawn of a new era?
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-022-00338-9
- By:
- Publication type:
- Article
Worth the paper they are printed on? Findings from an independent evaluation of the understandability of patient information leaflets for antiseizure medications.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 8, p. 2130, doi. 10.1111/epi.17299
- By:
- Publication type:
- Article
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00240-w
- By:
- Publication type:
- Article
Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2021, v. 14, p. 1517, doi. 10.2147/PGPM.S305068
- By:
- Publication type:
- Article
The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response.
- Published in:
- 2021
- By:
- Publication type:
- editorial
Where youth matters—clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer.
- Published in:
- Irish Journal of Medical Science, 2019, v. 188, n. 1, p. 59, doi. 10.1007/s11845-018-1832-z
- By:
- Publication type:
- Article
Detection of circulating tumour cell clusters in human glioblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 107, doi. 10.1007/s11060-018-2847-z
- By:
- Publication type:
- Article
Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach.
- Published in:
- Clinical Medicine Insights: Oncology, 2018, n. 12, p. 1, doi. 10.1177/1179554918759079
- By:
- Publication type:
- Article
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
MGMT promoter methylation status: time for a frank discussion.
- Published in:
- 2017
- By:
- Publication type:
- Letter